Stimulants and atomoxetine are the only effective interventions to reduce short-term adult ADHD symptoms, yet show limited evidence for long-term outcomes and quality of life improvements, according ...
Otsuka Pharma announces positive phase 3b results for centanafadine in adults with ADHD and comorbid anxiety: Tokyo, Japan Friday, June 26, 2026, 17:00 Hrs [IST] Otsuka Pharmaceut ...
A new study study tracks 37,600 families to link exclusive breastfeeding up to six months with a reduced risk of childhood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results